Plasminogen activator inhibitors from placenta and fibrosarcoma cells are antigenically different as evaluated with monoclonal and polyclonal antibodies.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Thrombosis Research

• Publication date

  1987-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0049-3848(87)90129-0PMID 2440126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormonal regulation of plasminogen activator in rat hepatoma cells

  2004cited by this paper
• Immunological Relationship Between the Fast-Acting Plasminogen Activator Inhibitors from Plasma, Blood Platelets and Endothelial Cells Demonstrated with a Monoclonal Antibody Against an Inhibitor from Placenta

  1986cited by this paper
• Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.

  1986cited by this paper
• General detection of proteins after electroblotting by trinitrobenzene sulphonic acid derivatization and immunochemical staining with a monoclonal antibody against the trinitrophenyl group.

  1986cited by this paper
• Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells

  1986cited by this paper
• Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.

  1986cited by this paper
• Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women

  1986cited by this paper
• Monoclonal Antibodies to Human 54,000 Molecular Weight Plasminogen Activator Inhibitor from Fibrosarcoma Cells - Inhibitor Neutralization and One-Step Affinity Purification

  1986cited by this paper
• The Dexamethasone-Induced Inhibitor of Plasminogen Activator in Hepatoma Cells Is Antigenically-Related to an Inhibitor Produced by Bovine Aortic Endothelial Cells

  1986cited by this paper
• Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.

  1986cited by this paper
• Isolation of a new specific plasminogen activator in hibitor from pregnancy plasma

  1986cited by this paper
• The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.

  1985cited by this paper
• Urokinase‐type plasminogen activator and its inhibitor secreted by cultured human monocyte‐macrophages

  1985cited by this paper
• The human urokinase-plasminogen activator gene and its promoter.

  1985cited by this paper
• Human Leucocyte Urokinase Inhibitor - Purification, Characterization and Comparative Studies Against Different Plasminogen Activators

  1985cited by this paper
• Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.

  1985cited by this paper
• Plasminogen activator in psoriatic scales is of the tissue‐type PA as identified by monoclonal antibodies

  1985cited by this paper
• Effects of the DNA intercalators 4'-(9-acridinylamino)methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II mediated DNA strand cleavage and strand passage.

  1985cited by this paper
• Protease nexin. Properties and a modified purification procedure.

  1985cited by this paper
• Different inhibition of one and two chain tissue plasminogen activator by a placental inhibitor studied with two tripeptide-p-nitroanilide substrates.

  1985cited by this paper
• Plasminogen activators, tissue degradation, and cancer.

  1985cited by this paper
• Purification of a Specific Placental Plasminogen Activator Inhibitor by Monoclonal Antibody and Its Complex Formation with Plasminogen Activator

  1985cited by this paper
• Concomitant secretion of prourokinase and of a plasminogen activator- specific inhibitor by cultured human monocytes-macrophages

  1984cited by this paper
• Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.

  1984cited by this paper
• Fibrinolysis: An Overview

  1984cited by this paper
• Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor

  1984cited by this paper
• Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.

  1984cited by this paper
• Detection and partial characterization of an inhibitor of plasminogen activator in human platelets.

  1984cited by this paper
• The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domains.

  1984cited by this paper
• Monoclonal antibody to human 66,000 molecular weight plasminogen activator from melanoma cells. Specific enzyme inhibition and one‐step affinity purification.

  1983cited by this paper
• Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.

  1983cited by this paper
• Evidence for a rapid inhibitor to tissue plasminogen activator in plasma.

  1983cited by this paper
• Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells.

  1983cited by this paper
• Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

  1983cited by this paper
• Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody.

  1982cited by this paper
• Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.

  1980cited by this paper
• On the Regulation and Control of Fibrinolysis

  1980cited by this paper
• Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus.

  1980cited by this paper
• Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction.

  1979cited by this paper
• Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells.

  1978cited by this paper
• ACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS

  1978cited by this paper
• An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.

  1978cited by this paper
• Serine enzymes released by cultured neoplastic cells

  1978cited by this paper
• On the proteolytic inhibitory effect of human foetal and neoplastic tissues.

  1976cited by this paper
• Inhibitory Effect of Placenta on Plasminogen Activation in Human Organ Culture 1

  1972cited by this paper
• Plasminogen: Purification from Human Plasma by Affinity Chromatography

  1970cited by this paper
• Urokinase Inhibitor in Human Placenta

  1968cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• From Fibrinolysis to the Plasminogen–Plasmin System and Beyond: A Remarkable Growth of Knowledge, with Personal Observations on the History of Fibrinolysis

  2014cites this paper
• Assessment of plasminogen activator inhibitor type 2 (PAI-2) as an imaging and therapeutic agent of human cancer

  2001cites this paper
• Occurrence of the specific plasminogen activator inhibitor of placental type, PAI-2 in ascitic fluid and tumour vessel blood from patients with ovarian carcinoma

  1990cites this paper
• Plasminogen activator inhibitor type 2 cDNA transfected into Chinese hamster ovary cells is stably expressed but not secreted

  1989cites this paper
• Urokinase binds to a plasminogen activator inhibitor type-2-like molecule in placental microvillous membranes.

  1989cites this paper
• Plasminogen activator inhibitor (PAI-2) in pregnancy plasma and ovarian cysts, studied by zymography after non-denaturing gel electrophoresis

  1989cites this paper
• Monoclonal Antibodies in Blood Coagulation

  1988cites this paper
• Determination of intermediates, products and cleavage site in the reaction between plasminogen activator inhibitor type‐2 and urokinases

  1988cites this paper
• The placental type plasminogen activator inhibitor, PAI 2

  1987cites this paper